Next Article in Journal
Application of Sodium Selenite in the Prevention and Treatment of Cancers
Next Article in Special Issue
Dupuytren’s and Ledderhose Diseases in a Family with LMNA-Related Cardiomyopathy and a Novel Variant in the ASTE1 Gene
Previous Article in Journal
Standard Assays for the Study of Autophagy in the Ex Vivo Retina
Previous Article in Special Issue
A Perspective on the Experimental Techniques for Studying Lamins
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessArticle
Cells 2017, 6(4), 38; https://doi.org/10.3390/cells6040038

Expression Profiling of Differentiating Emerin-Null Myogenic Progenitor Identifies Molecular Pathways Implicated in Their Impaired Differentiation

1
Department of Biomedical Sciences, Rm 534, Cooper Medical School of Rowan University, 401 South Broadway St., Camden, NJ 08028, USA
2
Department of Pharmaceutical Sciences, University of the Sciences, Philadelphia, PA 19104, USA
3
Committee on Genetics, Genomics and Systems Biology, University of Chicago, Chicago, IL 60637, USA
*
Author to whom correspondence should be addressed.
Received: 1 September 2017 / Revised: 18 October 2017 / Accepted: 18 October 2017 / Published: 22 October 2017
(This article belongs to the Collection Lamins and Laminopathies)
View Full-Text   |   Download PDF [8206 KB, uploaded 23 October 2017]   |  

Abstract

Mutations in the gene encoding emerin cause Emery-Dreifuss muscular dystrophy (EDMD), a disorder causing progressive skeletal muscle wasting, irregular heart rhythms and contractures of major tendons. RNA sequencing was performed on differentiating wildtype and emerin-null myogenic progenitors to identify molecular pathways implicated in EDMD, 340 genes were uniquely differentially expressed during the transition from day 0 to day 1 in wildtype cells. 1605 genes were uniquely expressed in emerin-null cells; 1706 genes were shared among both wildtype and emerin-null cells. One thousand and forty-seven transcripts showed differential expression during the transition from day 1 to day 2. Four hundred and thirty-one transcripts showed altered expression in both wildtype and emerin-null cells. Two hundred and ninety-five transcripts were differentially expressed only in emerin-null cells and 321 transcripts were differentially expressed only in wildtype cells. DAVID, STRING and Ingenuity Pathway Analysis identified pathways implicated in impaired emerin-null differentiation, including cell signaling, cell cycle checkpoints, integrin signaling, YAP/TAZ signaling, stem cell differentiation, and multiple muscle development and myogenic differentiation pathways. Functional enrichment analysis showed biological functions associated with the growth of muscle tissue and myogenesis of skeletal muscle were inhibited. The large number of differentially expressed transcripts upon differentiation induction suggests emerin functions during transcriptional reprograming of progenitors to committed myoblasts. View Full-Text
Keywords: emerin; Emery-Dreifuss muscular dystrophy; myogenic differentiation; lamin emerin; Emery-Dreifuss muscular dystrophy; myogenic differentiation; lamin
Figures

Figure 1a

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Iyer, A.; Koch, A.J.; Holaska, J.M. Expression Profiling of Differentiating Emerin-Null Myogenic Progenitor Identifies Molecular Pathways Implicated in Their Impaired Differentiation. Cells 2017, 6, 38.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top